Oxolinic acid for the treatment of chronic gastrointestinal Shigella carriers.
Two patients were long-term gastrointestinal carriers of Shigella flexneri for 23 mo and 6 mo, respectively. Neither patient responded to oral antibiotics, despite in vitro sensitivity of the bacteria to the antibiotics administered. Oral oxolinic acid produced immediate cessation of the carrier state in both patients, with resolution of minor but persistent physical complaints.
D000328:Adult; D002353:Carrier State / Q000188:drug therapy*; D002908:Chronic Disease; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D006801:Humans; D008297:Male; D010093:Oxolinic Acid / Q000627:therapeutic use*
D010093:Oxolinic Acid